Image Analysis’ team will be attending the 2nd annual Immuno-Oncology 360° conference, New York, USA. The annual meeting combines business and clinical development strategies with scientific updates to prepare the market for accelerating immuno-oncology clinical trials. Today, successful R&D of novel auto-immune treatments requires the most sensitive and responsive biomarkers for assessment of their efficacy and [...]
What we do+
We support clinical and pre-clinical studies and provide earlier, convincing evidence for a therapeutic effect in inflammatory arthritis and inflammatory cancers by utilizing advanced imaging, computer-aided scoring routines and patented methodologies.
Studies on early efficacy imaging markers for rheumatoid, psoriatic and osteoarthritis and ankylosis spondylitis patients imaged with MRI, DCE-MRI, Ultrasound, X-rays as well as computer-aided quantification of perfusion and morphology of tumors in inflammatory cancers.
Improving study economics, standardizing imaging and automating scoring routines for customers in pharmaceutical and biotech companies. Testimonials from our customers on use of Dynamika and Image Analysis team in their MRI clinical trials and studies
Innovation driven, agile and dedicated team, working in partnership with leading academics and clinical specialists and delivering the best medical imaging solutions and expert advice to ensure success of your clinical study.
Trial Support Service+
We deliver accurate and comprehensive image analytics and provide full support of early phase trials and R&D studies crucial to make go / no-go decision on further development of the compound.
We deliver the most comprehensive set of imaging markers and ensure that Sponsors and Investigators are fully informed of the treatment profile when making a decision on the success of the compound.
Clinical Trial Team+
Dedicated team of clinical and radiology experts, software engineers and algorithm developers will be engaged to deliver bespoke end-to-end support for your imaging study.
MRI as Early Biomarker+
Expert opinions and video lectures on the latest technologies for visualisation, analysis, and reporting of DCE-MRI and MRI images acquired in clinical or pre-clinical studies.
Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.
Your Study Initiation+
Deliverign yoru study on budget and on time with the cloud based infrastructure, patented scoring methodologies, innovate imaging, and network of experts.
Case studies and clinical routine examples of using advanced imaging and quantitative image markers for highly efficient interpretation and management of imaging data
Dynamika for FREE+
Dynamika is the best link between cutting academic research and clinical trial word. We ensure that you benefit from the latest science delivered within standardized regulated environment
E: info [at] imageanalysis.org.uk
T: + 44 (0) 20 7630 9926
Software and Project Support:
E: support [at] imageanalysis.org.uk
T: +44 (0) 78 12 001 187
Discuss your Study (Europe)Image Analysis Limited
QABC Minster House
272-274 Vauxhall Bridge Road
London, SW1V 1BA
Contact: Dr. Olga Kubassova
T: + 44 (0) 207 630 9926
E: info [at] imageanalysis.org.uk
Discuss your Study (United States)Image Analysis Ltd
175 Atlantic Street
Contact: John Garber
T: + 12 036 736 911
E: john.garber [at] imageanalysis.org.uk
Image Analysis – a world-leading digital services company focused on MRI – is looking for a world-class Chief Commercial Officer / SVP Revenue to drive our client development, sales and the business expansion. We assist global bio-Pharmaceutical companies developing new compounds in the fast-developing areas of immunology and oncology. Working closely with the CEO and the rest of the top team, you will personally [...]
Meet Image Analysis Team & our Clinical Advisory Board Members at ACR-American College of Rheumatology Annual Meeting 2015 (Nov 7-11), Booth 314 to schedule a meeting: UK: + 44 207 630 9926 USA: +1 203 673 6911 firstname.lastname@example.org The impetus for Image Analysis’ offering is based on the limitations of existing biomarkers, and the quest for a non-invasive indicator of [...]
We would like to share some insights from a fascinating post on how innovation can disrupt the normal routine of healthcare, written by Clayton M. Christensen, Richard Bohmer, and John Kenagy, Harvard Business School, and a clinical associate professor of surgery at the University of Washington in Seattle. Imagine a portable, low-intensity X-ray machine that can be wheeled between offices on a small cart. [...]
Abstract accepted for ISMRM-ESMRMB: Preliminary Results of Metabolic-flow relationship in primary cervical cancer: correlation of combined PET/Dynamic contrast-enhanced MRI
Purpose Worldwide, cervical cancer is the second most common cancer in women (after breast cancer), with more than half a million new cases diagnosed in 2005. Novel imaging techniques using magnetic resonance (MR) and positron emission tomography (PET) can facilitate time resolved spatial evaluation of biological characteristics (perfusion, permeability, cellularity, proliferation, oxygenation, and apoptosis) thereby [...]
Abstract accepted for SMRT at ISMRM 2014: Quantitative analysis of the first pass series in the heart: a preview of new possibilities using motion correction and colour maps
Background Cardiovascular magnetic resonance perfusion imaging has become an important tool for diagnosis, prognosis and management of cardiovascular diseases. Dynamic contrast enhanced series are commonly used in the heart. First-pass series in which the heart is repeatedly imaged during the first pass of a contrast agent can provide us with additional information about the state [...]